These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17160026)

  • 1. All together now?
    Nat Biotechnol; 2006 Dec; 24(12):1454. PubMed ID: 17160026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European markets target foreign biotechs.
    Louët S
    Nat Biotechnol; 2003 Jul; 21(7):719. PubMed ID: 12833075
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechs await single European financial market.
    Louët S
    Nat Biotechnol; 2003 Dec; 21(12):1417. PubMed ID: 14647312
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rise of venture capital and biotechnology in the US and Europe.
    Lee DP; Dibner MD
    Nat Biotechnol; 2005 Jun; 23(6):672-6. PubMed ID: 15940233
    [No Abstract]   [Full Text] [Related]  

  • 6. White biotech and the financial crisis.
    Rabinovich M
    Biotechnol J; 2009 Aug; 4(8):1117-23. PubMed ID: 19685465
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech stocks struggle as financial markets tumble.
    Mitchell P
    Nat Biotechnol; 2002 Aug; 20(8):755-6. PubMed ID: 12147984
    [No Abstract]   [Full Text] [Related]  

  • 8. The perils of subsidiarity.
    Nat Biotechnol; 2004 Dec; 22(12):1483. PubMed ID: 15583638
    [No Abstract]   [Full Text] [Related]  

  • 9. BTJ Forum: Biotech in the financial crisis.
    Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
    [No Abstract]   [Full Text] [Related]  

  • 10. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 11. Europe refuses to match US cash for ailing Global Fund.
    Bosch X
    Lancet; 2003 Jul; 362(9380):299. PubMed ID: 12892981
    [No Abstract]   [Full Text] [Related]  

  • 12. A reprise for collaborative financing in biotech.
    Ransom J
    Nat Biotechnol; 2006 Aug; 24(8):873-4. PubMed ID: 16900110
    [No Abstract]   [Full Text] [Related]  

  • 13. Minicrash tests biotechnology investors and companies as market fluctuates.
    Dorey E
    Nat Biotechnol; 1997 Dec; 15(13):1333. PubMed ID: 9415878
    [No Abstract]   [Full Text] [Related]  

  • 14. Impossible fixes.
    Nat Biotechnol; 2010 Feb; 28(2):103. PubMed ID: 20139925
    [No Abstract]   [Full Text] [Related]  

  • 15. US government previews biotech survey.
    Goho A
    Nat Biotechnol; 2003 Aug; 21(8):837-8. PubMed ID: 12894185
    [No Abstract]   [Full Text] [Related]  

  • 16. OECD says industrial biotech not realizing potential.
    Niiler E
    Nat Biotechnol; 2001 Jun; 19(6):493-4. PubMed ID: 11385413
    [No Abstract]   [Full Text] [Related]  

  • 17. Ambitious French biotech plan faces EU hurdle.
    Hodgson J
    Nat Biotechnol; 2003 Feb; 21(2):113-4. PubMed ID: 12560821
    [No Abstract]   [Full Text] [Related]  

  • 18. Crisis in the United Nations, NATO and the European Union.
    Lucas C
    Med Confl Surviv; 2003; 19(4):275-84. PubMed ID: 14703126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientists and societies. The Polish biotech gap.
    Gorlach S; Slabicki M
    Nature; 2004 Feb; 427(6977):870. PubMed ID: 14985771
    [No Abstract]   [Full Text] [Related]  

  • 20. Market woes drag down biotech shares.
    Morrison C
    Nat Biotechnol; 2001 Nov; 19(11):995-6. PubMed ID: 11689828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.